Discovery of a new mechanism of gene control that is associated with cancer

	Tweet

Researchers headed by Joan Massagué at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and by María Macías at the Institute for Research in Biomedicine (IRB Barcelona) have identified a complex mechanism by which some proteins that are essential for life, called Smads, regulate the activity of genes associated with cancer. The fruit of three years of intense work, the study reports on the life cycle of this protein, a process that ensures that the protein is destroyed when it has completed its function. These results have been published today in the top journal Genes & Development, which has devoted its cover to this research.

In the TGF-beta/Smad signal cascade, the hormones TGF-beta and BMP transmit information to the Smad protein in the cell nucleus in order for this molecule to stop cell division and to ensure that tissues grow in an orderly and coordinated manner. Although the TGF-beta/Smad signalling pathway has been known for over twenty years, until now it was unclear how Smads temporally controlled the activity of such important genes. “We had several pieces of the puzzle but we couldn’t put them together”, says Macías.

A number of earlier studies performed by Massagué’s lab had identified that Smads undergo phosphorylations –a kind of chemical change – in a region of the protein about which little is known. By means of biophysical and biochemical approaches, the researchers have discovered that these modifications occur in a coordinated fashion over time and are not random.

“First, phosphorylations make some proteins bind to Smads in order to control the activity of target genes and later other phoshorylations cause protein bindings that lead to the destruction of Smad once this protein has completed its mission. This is the way cells prevent fatal errors”, explains Macías.

Having established the time sequence of these events, the scientists used cell and structural biology approaches –determination of the atom position in Smad proteins and other activating and destructor proteins bound to them– to confirm the results previously found. “We have been able to decipher the specificity of the binding between Smad and other proteins and to reveal the secret code that these proteins use to extract information”.

How do these proteins favour tumour cells? Massagué explains that “these signalling cascades are like the body’s pólice force. The tumour cells, in other words the delinquents, disturb these pathways and use them for their own means to grow and spread”. These pathways normally are involved in basic cell processes but when altered by mutations several diseases can appear such as cancer, congenital conditions, chronic inflammation and emphysema. These results could serve as the foundation on which to develop new clinical treatments against cancer and other diseases.

Reference article:
A Smad action-turnover switch operated by WW domain readers of a phosphoserine code. Eric Aragón, Nina Goerner, Alexia-Ileana Zaromytidou, Qiaoran Xi, Albert Escobedo, Joan Massagué, and Maria J. Macias.
Genes & Development (2011). [doi: 10.1101/gad.2060811]

###

Sònia Armengou
Media relations
Tel:+34 93 403 72 55
Fax:+34 93 403 71 14
sonia.armengouarrobairbbarcelona.org
Institute for Research in Biomedicine (IRB Barcelona)

RELATED STORIES:
If you think cancer genes are simple, you don’t know JAK   Ben-Gurion U. researchers reveal connection between cancer and human evolution   Doctors Hesitate to Discuss Fertility Preservation With Cancer Patients   New Study Begins for Kids With High-Risk Cancer   Fruit research yields way to curb cancer   Chemotherapy Complications Greater than Previously Estimated   Cancer drug may fight smallpox, study suggests   Washington University Scientists First to Sequence Genome of Cancer Patient   Green tea doesn’t lower cancer risk, U.S. FDA says   Botox Could Help Target Resistant Tumors for Treatment   Many male cancer patients are missing out on sperm banking   Antibody signal may redirect inflammation to fuel cancer   UNC study supports role of circadian clock in response to chemotherapy   Ark says cancer therapy potent, cuts side-effects   Epilepsy does not appear to increase cancer risk   Betel quid chewing increases pharyngeal cancer risk   New Gene for Childhood Cancer Neuroblastoma Is Discovered   Compound that blocks sugar pathway slows cancer cell growth   How to Prevent Radiation Mistakes in Cancer Patients   Nicotine promotes growth of established tumors   Study reveals cancer-linked epigenetic effects of smoking   Genes set scene for metastasis

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]